Translational Research Institute
The Translational Research Institute (TRI) is a unique, Australian-first initiative of 'bench to bedside' medical research. TRI combines clinical and translational research to advance progress from laboratory discovery to application in the community.
The collective expertise of TRI's founding partners; The University of Queensland, Queensland University of Technology, Mater Research Institute and Queensland Health is brought to bear on common and serious disease including cancers, diabetes, inflammatory diseases, HIV, malaria, bone and joint diseases and obesity, with a view to enhanced prevention and treatment and improved public health worldwide.
Health Consumer Research EXPO 2025
Семинар TRI Game Changer с участием Розмари Хакстейбл
Санофи — первый арендатор объекта TRI ENTRI
MPs visit TRI and ENTRI
Study finds correlation between diet and mental health
ENTRI announced as the name of TRI's translational manufacturing hub
ACCISS, a TRI industry-enabling success story
What is Translational Research?
TRI Game Changer Seminar featuring Professor John Mattick
TRI Biomedical Careers Day 2025
Building & Maintaining Your Professional Brand
Bridging Sectors: Careers in Translational Research and Beyond
Engagement with Intent - When, Where, Why and How
Roles in the Life Sciences Sector – Now and in the Future
Clinical trials at Translational Research Institute
Abalone may unlock new treatment for Inflammatory Bowel Disease
Evidence alcohol, even prior to conception, may harm the placenta baby
SPARQ-ed Programs
TRI's new Translational Manufacturing facility explained.
Translational Manufacturing Facility at the Translational Research Institute
Celebrating 2024 at TRI
How nature may provide the key to beating drug resistant melanoma
Translational manufacturing facility construction update
TRI EMCR Cancer Seminar Series 6 August 2024
TRI Game Changers 2024 featuring Prof Jennifer Martin
Visit to TRI by Federal Industry and Science Minister Ed Husic
Potential new treatment pathway for bladder cancer